No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

TransformativeMed Offering a COVID-19/Core Work Manager App to Seattle-Area Hospitals/Medical Centers Free of Charge During the COVID-19 Outbreak

Editor: What To Know

  • The application is being implemented at another Seattle-based health system now, and it will be deployed at other hospitals and health systems in the U.
  • “All of us at TransformativeMed are committed to combatting this deadly virus, and our staff has been working tirelessly to modify and implement our CORES application for COVID-19,”.
  • “With current resource limitations, it is imperative that we have technology solutions that help us track potential COVID-19 cases as well as monitor those that are already in the system,”.

COVID-19/CORES is already being used at UW Medicine, which includes the University of Washington Medical Center and Harborview Medical Center. The application is being implemented at another Seattle-based health system now, and it will be deployed at other hospitals and health systems in the U.S. in the next few days.

“With current resource limitations, it is imperative that we have technology solutions that help us track potential COVID-19 cases as well as monitor those that are already in the system,” said Erik Van Eaton, MD, a faculty member at the University of Washington who specializes in trauma and surgical critical care. “This application is critical for our tracking of suspected and confirmed cases. It provides better processes, workflows and an improved communication platform for both internal care team communications as well as data delivery to the health department. We have definitely seen an increased ability to organize our treatment of patients.”

The existing CORES app provides specialty-specific workflow and content, integrates workflows and coordinates patient handoffs. A development team at TransformativeMed has worked around the clock to make program updates customized for COVID-19.

“All of us at TransformativeMed are committed to combatting this deadly virus, and our staff has been working tirelessly to modify and implement our CORES application for COVID-19,” said Doug Cusick, CEO. “We are closely monitoring how the end users are working with the app and making modifications and adjustments where necessary so we can continue improving care delivery and monitoring virus cases in these institutions.”

In the next few days, TransformativeMed plans to make its COVID-19/CORES application free of charge during the coronavirus outbreak to other hospitals and health systems. For more information, please visit transformativemed.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy